MENU
+Compare
CNTX
Stock ticker: NASDAQ
AS OF
Jul 15, 04:59 PM (EDT)
Price
$0.72
Change
-$0.01 (-1.37%)
Capitalization
65.68M

CNTX Context Therapeutics Forecast, Technical & Fundamental Analysis

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors... Show more

CNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CNTX with price predictions
Jul 14, 2025

CNTX's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for CNTX turned positive on June 25, 2025. Looking at past instances where CNTX's MACD turned positive, the stock continued to rise in of 32 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 26, 2025. You may want to consider a long position or call options on CNTX as a result. In of 60 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

CNTX moved above its 50-day moving average on July 14, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CNTX advanced for three days, in of 164 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CNTX broke above its upper Bollinger Band on July 14, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CNTX entered a downward trend on June 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.722) is normal, around the industry mean (17.480). P/E Ratio (0.000) is within average values for comparable stocks, (59.327). CNTX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.459). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (273.307).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CNTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CNTX is expected to report earnings to rise 18.40% to -5 cents per share on August 06

Context Therapeutics CNTX Stock Earnings Reports
Q2'25
Est.
$-0.06
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.03
Q3'24
Missed
by $0.17
Q2'24
Beat
by $0.03
The last earnings report on May 07 showed earnings per share of -5 cents, beating the estimate of -11 cents. With 160.14K shares outstanding, the current market capitalization sits at 65.68M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2001 Market Street
Phone
+1 267 225-7416
Employees
5
Web
https://www.contexttherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APXYY0.370.04
+12.21%
Appen Ltd.
WHYRF0.32N/A
+0.65%
West High Yield Resources Ltd.
DTCWY13.50N/A
N/A
Deutsche Wohnen SE
AMBKP7.75N/A
N/A
American Capital Trust I
OVHFF12.13N/A
N/A
OVH GROUPE

CNTX and Stocks

Correlation & Price change

A.I.dvisor tells us that CNTX and OBIO have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNTX and OBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTX
1D Price
Change %
CNTX100%
+9.27%
OBIO - CNTX
30%
Poorly correlated
+3.77%
ABSI - CNTX
30%
Poorly correlated
-0.37%
ADVM - CNTX
29%
Poorly correlated
+7.48%
CMMB - CNTX
29%
Poorly correlated
+1.18%
IPSC - CNTX
29%
Poorly correlated
-0.07%
More